Meet SRG’s Orange Paper USA!

Igor Stefanov CEO @ SRG CRO & A Kingsman @ ACROSS Global™ I’m pleased to introduce to you the new edition of our Orange Paper analysing clinical trials in the USA during Q3 2018. Meet the new USA member of SRG’s Orange Paper family! Worldwide Trials Up 19% According to ClinicalTrials.gov, 6,396 new clinical trials […]

Clinical Study Risk Visualization: Seeing is Believing

Igor Stefanov CEO @ SRG CRO & A Kingsman @ ACROSS Global™ The sun rises soon after the rooster crows. What is the rooster in this case? Is the rooster a source of risk or just a key risk indicator? Is there a risk that sun will not rise, once the rooster doesn’t crow? With […]

Clinical Trial Risk Assessment: Don’t Ask Stupid Questions

Igor Stefanov CEO @ SRG CRO & A Kingsman @ ACROSS Global™ Our modern “Risk Assessment” is very similar to that of the ancient art of divination. Technology is different, but objectives are the same. We try to predict the future, identify and evaluate the potential hazards and understand how to avoid them. Instead of […]

How We Failed to Implement Risk Based Monitoring

Igor Stefanov CEO @ SRG CRO & A Kingsman @ ACROSS Global™ Even though I’m an engineer by my first education, I don’t believe solely in technology. I believe in common sense and good reasoning. Both are rare nowadays. The pharmaceutical industry is no exception. Risk management isn’t anything but common sense. Risk Based Monitoring […]

  1. Pages:
  2. 1
  3. 2